3.4.21.89	-	653816	
3.4.21.89	cubic crystalsdifferent variants, Lbpro-C51A, space group P4(1)32, unit cell a : 275.5 A, sLbpro-C51A-C133S, space group P2(1), a : 46.0, b : 110.8, c : 57.0	137299	
3.4.21.89	dynamic conformational changes of soluble, catalytically active variant DELTA2-75	732894	
3.4.21.89	mutant delta2-75 in complex with beta-lactam inhibitor (5S,6S) penem, crystals belong to orthorhombic space group P2(1)2(1)2 with unit cell dimensions a : 110.7 A, b : 113.2 A, c : 99.2 A, crystal structure of apoenzyme in absence of substrate or inhibitor solved by molecular replacement, space group P4(1)2(1)2, unit cell dimensions a : b : 112.4 A, c : 198.7 A	653334	
3.4.21.89	presence of Triton X-100 is required to obtain crystals sufficiently large for X-ray analysis	29828	
3.4.21.89	soluble catalytic domain of SSPase I in ternary complex with inhibitors arylomycin A2 and BAL0019193, sitting drop vapor diffusion method at 18°C, mixing of 0.002 ml of protein solution and of reservoir solution, containing 0.2 M ammonium formate, 25% PEG 2000, 0.1 M sodium cacodylate pH 6.5, and 5% tertiary-amyl alcohol, equilibration over 1 ml reservoir solution, X-ray diffraction structure determination and analysis at 2.0 A resolution, molecular replacement	707513	
3.4.21.89	to 2.05 A resolution, monoclinic space group P21	731089